
Whereas some chief executives throughout industries see restricted enterprise alternatives in healthcare following the U.S. presidential election, others view it as a average threat, in response to the most recent Fortune/Deloitte survey.
Fortune/Deloitte surveyed 141 CEOs throughout greater than 20 industries for its fall 2024 CEO survey. Leaders surveyed in November embody chief executives from the Fortune 500, Fortune International 500, and different prime firms. 9 % of survey respondents had been from healthcare and life sciences.
4 survey findings:
1. Of the CEOs surveyed, 22% see restricted alternatives in healthcare, 40% view it as a average threat, and 39% stay impartial.
2. Eighty-four % of chief executives reported optimism about their firm’s efficiency over the subsequent 12 months.
3. Forty-two % of survey respondents are optimistic concerning the international financial system, up from 29% in the summertime.
4. Sixty-six % of survey respondents see alternative in synthetic intelligence.
Learn extra concerning the survey right here.